Company
United StatesPublic company, NYSE: LLYEli Lilly and Company (NYSE: LLY), Pleasant Prairie, WI – FDA Inspections
Inspection records and compliance data for Eli Lilly and Company in Pleasant Prairie, WI. 1 FDA inspection on record, 1 Form 483, last inspected September 11, 2025. Publicly traded as NYSE: LLY.
Company Profile
This profile covers Eli Lilly and Company based in Pleasant Prairie, WI, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 1
- Warning letters
- 0
Inspected September 11, 2025.
Most cited issue areas
- Investigations of discrepancies, failures1 inspection
- Procedures for sterile drug products1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 11, 2025 | VAI | Human Drugs · New Drug Evaluation | 1282100 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Eli Lilly and Company
Stock ticker
LLY
Exchange
NYSE
Share price
$1,430.13
Market cap
$1.3T
Price as of
November 13, 2026
FEI Number
3031961517
Address
10300 128th Ave, Pleasant Prairie, WI 53158-7336, United States
Country
United States
ID: 8a6d3dc2-168f-4196-8a63-12b1f113e12a